A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis
Trial · NCT03798366
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in mRSS at Week 4 | GLPG1690 600 mg | -2.2 | Standard Error 0.85 | units on a scale | |
| Change From Baseline in mRSS at Week 4 | Placebo | -1.6 | Standard Error 1.04 | units on a scale | |
| Change From Baseline in mRSS at Week 8 | GLPG1690 600 mg | -3.2 | Standard Error 0.85 | units on a scale | |
| Change From Baseline in mRSS at Week 8 | Placebo | -2.5 | Standard Error 1.07 | units on a scale | |
| Change From Baseline in mRSS at Week 16 | GLPG1690 600 mg | -6.8 | Standard Error 0.85 | units on a scale | |
| Change From Baseline in mRSS at Week 16 | Placebo | -4.8 | Standard Error 1.12 | units on a scale | |
| Change From Baseline in mRSS at Week 24 | GLPG1690 600 mg | -8.9 | Standard Error 0.87 | units on a scale | |
| Change From Baseline in mRSS at Week 24 | Placebo | -6.0 | Standard Error 1.11 | units on a scale | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | GLPG1690 600 mg | TEAEs | 20 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Placebo | TEAEs | 11 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | GLPG1690 600 mg | Serious TEAEs | 2 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious TEAEs | Placebo | Serious TEAEs | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03798366/results